Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Folic Acid | 8 | 2014 | 42 | 1.400 |
Why?
|
| Homocysteine | 7 | 2014 | 33 | 1.010 |
Why?
|
| Folic Acid Deficiency | 8 | 2009 | 8 | 0.800 |
Why?
|
| Apolipoproteins E | 8 | 2005 | 115 | 0.560 |
Why?
|
| Oxidative Stress | 12 | 2009 | 317 | 0.550 |
Why?
|
| Vitamin E Deficiency | 7 | 2009 | 9 | 0.460 |
Why?
|
| Dietary Supplements | 3 | 2014 | 236 | 0.460 |
Why?
|
| Methionine | 2 | 2014 | 57 | 0.450 |
Why?
|
| Cognition Disorders | 3 | 2014 | 224 | 0.420 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 119 | 0.370 |
Why?
|
| Nerve Degeneration | 4 | 2004 | 68 | 0.300 |
Why?
|
| Aging | 2 | 2014 | 773 | 0.300 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2008 | 8 | 0.280 |
Why?
|
| Neural Tube Defects | 1 | 2008 | 28 | 0.270 |
Why?
|
| Selection, Genetic | 1 | 2008 | 90 | 0.270 |
Why?
|
| Antioxidants | 4 | 2005 | 249 | 0.260 |
Why?
|
| Vitamin E | 3 | 2005 | 55 | 0.250 |
Why?
|
| S-Adenosylmethionine | 4 | 2014 | 31 | 0.230 |
Why?
|
| Neurons | 4 | 2005 | 933 | 0.230 |
Why?
|
| Autistic Disorder | 1 | 2008 | 159 | 0.230 |
Why?
|
| Brain | 5 | 2005 | 1609 | 0.210 |
Why?
|
| Alleles | 1 | 2004 | 455 | 0.190 |
Why?
|
| Alzheimer Disease | 4 | 2012 | 765 | 0.160 |
Why?
|
| Pregnancy | 3 | 2014 | 2392 | 0.160 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 4 | 2005 | 16 | 0.130 |
Why?
|
| Acetylcysteine | 2 | 2005 | 25 | 0.110 |
Why?
|
| Mice | 12 | 2012 | 11125 | 0.100 |
Why?
|
| Vitamin B Complex | 1 | 2014 | 15 | 0.100 |
Why?
|
| Vitamin B 12 | 1 | 2014 | 18 | 0.100 |
Why?
|
| Animals | 14 | 2012 | 21356 | 0.090 |
Why?
|
| Prenatal Care | 1 | 2014 | 173 | 0.090 |
Why?
|
| Amyloid beta-Peptides | 2 | 2005 | 320 | 0.090 |
Why?
|
| Nutritional Status | 1 | 2012 | 101 | 0.080 |
Why?
|
| Apolipoprotein E4 | 2 | 2009 | 46 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 5 | 2005 | 3483 | 0.080 |
Why?
|
| tau Proteins | 2 | 2009 | 209 | 0.080 |
Why?
|
| Mice, Knockout | 6 | 2005 | 2161 | 0.080 |
Why?
|
| Glutathione | 3 | 2004 | 54 | 0.070 |
Why?
|
| Reactive Oxygen Species | 3 | 2005 | 237 | 0.070 |
Why?
|
| Neuroblastoma | 2 | 2005 | 54 | 0.070 |
Why?
|
| Dementia | 1 | 2012 | 285 | 0.070 |
Why?
|
| Cerebral Cortex | 3 | 2005 | 269 | 0.070 |
Why?
|
| Humans | 9 | 2014 | 65385 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2008 | 198 | 0.060 |
Why?
|
| Cells, Cultured | 4 | 2005 | 2187 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2009 | 1290 | 0.060 |
Why?
|
| Female | 3 | 2014 | 34146 | 0.060 |
Why?
|
| Acetylcarnitine | 1 | 2005 | 4 | 0.060 |
Why?
|
| Vitamins | 1 | 2005 | 80 | 0.060 |
Why?
|
| Disease Models, Animal | 4 | 2004 | 2304 | 0.050 |
Why?
|
| Ganglia, Spinal | 1 | 2004 | 30 | 0.050 |
Why?
|
| Tubercidin | 1 | 2004 | 2 | 0.050 |
Why?
|
| Adenine | 1 | 2004 | 48 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2005 | 169 | 0.050 |
Why?
|
| Calcium | 2 | 2004 | 584 | 0.050 |
Why?
|
| Neuroprotective Agents | 1 | 2004 | 78 | 0.050 |
Why?
|
| Iron, Dietary | 1 | 2002 | 9 | 0.050 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2002 | 21 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 426 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2005 | 200 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2005 | 318 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2002 | 103 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2004 | 234 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2002 | 153 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2002 | 328 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2003 | 373 | 0.040 |
Why?
|
| Neurodegenerative Diseases | 1 | 2003 | 152 | 0.040 |
Why?
|
| DNA Damage | 1 | 2002 | 298 | 0.040 |
Why?
|
| Liver | 1 | 2002 | 870 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2009 | 961 | 0.020 |
Why?
|
| Maze Learning | 2 | 2004 | 51 | 0.020 |
Why?
|
| Male | 1 | 2014 | 31147 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2005 | 1566 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2005 | 142 | 0.010 |
Why?
|
| Diet, Protein-Restricted | 1 | 2005 | 12 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2005 | 83 | 0.010 |
Why?
|
| Nimodipine | 1 | 2004 | 3 | 0.010 |
Why?
|
| Xanthenes | 1 | 2004 | 9 | 0.010 |
Why?
|
| Thapsigargin | 1 | 2004 | 17 | 0.010 |
Why?
|
| Dizocilpine Maleate | 1 | 2004 | 11 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2004 | 46 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 158 | 0.010 |
Why?
|
| Aniline Compounds | 1 | 2004 | 40 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2005 | 312 | 0.010 |
Why?
|
| Glutathione Synthase | 1 | 2004 | 2 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2005 | 298 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2004 | 140 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2003 | 12 | 0.010 |
Why?
|
| Cytosol | 1 | 2004 | 182 | 0.010 |
Why?
|
| Neurotoxins | 1 | 2002 | 21 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 401 | 0.010 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2002 | 90 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 1630 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2002 | 391 | 0.010 |
Why?
|
| Iron | 1 | 2002 | 154 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 213 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 857 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2003 | 506 | 0.010 |
Why?
|
| Mitochondria | 1 | 2004 | 409 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2003 | 733 | 0.010 |
Why?
|